Literature DB >> 33446761

Differentially expressed lncRNAs in liver tissues of TX mice with hepatolenticular degeneration.

Juan Zhang1, Ying Ma2, Daojun Xie3, Yuancheng Bao3, Wenming Yang3, Han Wang3, Huaizhou Jiang4, Hui Han3, Ting Dong3.   

Abstract

Wilson's Disease (WD), an ATP7B-mutated inherited disease that affects copper transport, is characterised by liver and nervous system manifestations. Long non-coding (ln-c) RNAs are widely involved in almost all physiological and pathological processes in the body, and are associated with numerous diseases. The present study aimed to elucidate the lncRNA-mRNA regulation network in a TX WD mouse model using RNA sequencing (RNA-seq). lncRNA expression profiles were screened using RNA-seq and real-time polymerase chain reaction, and differentially expressed lncRNAs and mRNAs were identified. To analyse the biological functions and pathways for the differentially expressed mRNAs, gene ontology and pathway enrichment analyses were performed. A significantly correlated lncRNA-mRNA relationship pair was calculated by CNC analysis to construct differential lncRNA and mRNA co-expression networks. A total of 2564 significantly up-regulated and 1052 down-regulated lncRNAs, and 1576 up-regulated and 297 down-regulated mRNAs, were identified. These genes were found to be associated with key processes such as apoptosis, and KEGG analysis revealed enrichment in the drug metabolism-cytochrome P450 pathway, PPAR signalling pathway, Notch signalling pathway, and MAPK signalling pathway. The identified differential lncRNAs may be involved in the pathogenesis and development of WD liver injury.

Entities:  

Year:  2021        PMID: 33446761      PMCID: PMC7809420          DOI: 10.1038/s41598-020-80635-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  33 in total

Review 1.  Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases.

Authors:  Puneet Chopra; Vijay Kanoje; Arvind Semwal; Abhijit Ray
Journal:  Expert Opin Investig Drugs       Date:  2008-10       Impact factor: 6.206

2.  LncRNAs expression in adriamycin-induced rats reveals the potential role of LncRNAs contributing to chronic glomerulonephritis pathogenesis.

Authors:  Xiu-Juan Qin; Jia-Rong Gao; Xian-Jin Xu; Hui Jiang; Liang-Bing Wei; Nan-Nan Jiang
Journal:  Gene       Date:  2018-11-17       Impact factor: 3.688

3.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks.

Authors:  Cole Trapnell; Adam Roberts; Loyal Goff; Geo Pertea; Daehwan Kim; David R Kelley; Harold Pimentel; Steven L Salzberg; John L Rinn; Lior Pachter
Journal:  Nat Protoc       Date:  2012-03-01       Impact factor: 13.491

Review 4.  Chemotherapy and targeted therapy for gall bladder cancer.

Authors:  Bhawna Sirohi; Ashish Singh; P Jagannath; Shailesh V Shrikhande
Journal:  Indian J Surg Oncol       Date:  2014-06-03

5.  The toxic milk mouse is a murine model of Wilson disease.

Authors:  M B Theophilos; D W Cox; J F Mercer
Journal:  Hum Mol Genet       Date:  1996-10       Impact factor: 6.150

6.  MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis.

Authors:  Fujun Yu; Zhongqiu Lu; Jing Cai; Kate Huang; Bicheng Chen; Guojun Li; Peihong Dong; Jianjian Zheng
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats.

Authors:  Zheng Wang; Jia-Peng Xu; Yong-Chao Zheng; Wei Chen; Yong-Wei Sun; Zhi-Yong Wu; Meng Luo
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2011-02

Review 8.  Long non-coding RNAs: An essential emerging field in kidney pathogenesis.

Authors:  Hakimeh Moghaddas Sani; Mina Hejazian; Seyed Mahdi Hosseinian Khatibi; Mohammadreza Ardalan; Sepideh Zununi Vahed
Journal:  Biomed Pharmacother       Date:  2018-02-20       Impact factor: 6.529

Review 9.  Long non-coding RNAs: crucial regulators of gastrointestinal cancer cell proliferation.

Authors:  Jiaxin Chen; Shuiping Liu; Xiaotong Hu
Journal:  Cell Death Discov       Date:  2018-04-27

10.  ATF4 deficiency protects hepatocytes from oxidative stress via inhibiting CYP2E1 expression.

Authors:  Chunxia Wang; Houkai Li; Qingshu Meng; Ying Du; Fei Xiao; Qian Zhang; Junjie Yu; Kai Li; Shanghai Chen; Zhiying Huang; Bin Liu; Feifan Guo
Journal:  J Cell Mol Med       Date:  2013-11-06       Impact factor: 5.310

View more
  2 in total

1.  Construction of a Novel circRNA/miRNA/mRNA Regulatory Network to Explore the Potential Pathogenesis of Wilson's Disease.

Authors:  Taohua Wei; Nannan Qian; Wenming Yang; Yue Yang; Jie Liu; Wenjie Hao; Ting Cheng; Ran Yang; Wei Dong; Yulong Yang
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

Review 2.  Wilson Disease: Update on Pathophysiology and Treatment.

Authors:  Som Dev; Robert L Kruse; James P Hamilton; Svetlana Lutsenko
Journal:  Front Cell Dev Biol       Date:  2022-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.